Meta-analysis of upfront VEGF targeted therapy prior to nephrectomy in metastatic clear cell renal cancer.

被引:0
|
作者
Wimalasingham, Akhila Ganeshi
Lista, Alfonso Gomez de Liano
de Bruijn, Roderick
Haanen, John B. A. G.
Szabados, Bernadett
Hall, Peter
机构
关键词
D O I
10.1200/JCO.2017.35.6_suppl.514
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
514
引用
收藏
页数:1
相关论文
共 50 条
  • [41] THE ROLE OF NEPHRECTOMY IN METASTATIC RENAL CELL CARCINOMAIN THE ERA OF IMMUNE-COMBINATIONTHERAPIES: A META-ANALYSIS
    Mori, Keiichiro
    Quhal, Fahad
    Yanagisawa, Takafumi
    Katayama, Satoshi
    Pradere, Benjamin
    Laukhtina, Ekaterina
    Rajwa, Pawel
    Mostafaei, Hadi
    Motlagh, Reza Sari
    Kimura, Takahiro
    Egawa, Shin
    Bensalah, Karim
    Karakiewicz, Pierre
    Schmidinger, Manuela
    Shariat, Shahrokh
    JOURNAL OF UROLOGY, 2022, 207 (05): : E172 - E173
  • [42] Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis
    Britton, Cameron J.
    Andrews, Jack R.
    Wallis, Christopher J. D.
    Sharma, Vidit
    Leibovich, Bradley C.
    Thompson, R. Houston
    Boorjian, Stephen A.
    Bhindi, Bimal
    Costello, Brian A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (03) : 125 - 136
  • [43] Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis
    Tsao, Che-kai
    Small, Alexander C.
    Kates, Max
    Moshier, Erin L.
    Wisnivesky, Juan P.
    Gartrell, Benjamin A.
    Sonpavde, Guru
    Godbold, James H.
    Palese, Michael A.
    Hall, Simon J.
    Oh, William K.
    Galsky, Matthew D.
    WORLD JOURNAL OF UROLOGY, 2013, 31 (06) : 1535 - 1539
  • [44] Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies
    Golshayan, Ali-Reza
    Brick, Ashley J.
    Choueiri, Toni K.
    FUTURE ONCOLOGY, 2008, 4 (01) : 85 - 92
  • [45] Metastatic renal cell cancer treatments: An indirect comparison meta-analysis
    Edward J Mills
    Beth Rachlis
    Chris O'Regan
    Lehana Thabane
    Dan Perri
    BMC Cancer, 9
  • [46] Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis
    Che-kai Tsao
    Alexander C. Small
    Max Kates
    Erin L. Moshier
    Juan P. Wisnivesky
    Benjamin A. Gartrell
    Guru Sonpavde
    James H. Godbold
    Michael A. Palese
    Simon J. Hall
    William K. Oh
    Matthew D. Galsky
    World Journal of Urology, 2013, 31 : 1535 - 1539
  • [47] Metastatic renal cell cancer treatments: An indirect comparison meta-analysis
    Mills, Edward J.
    Rachlis, Beth
    O'Regan, Chris
    Thabane, Lehana
    Perri, Dan
    BMC CANCER, 2009, 9
  • [48] The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
    Powles, T.
    Kayani, I.
    Blank, C.
    Chowdhury, S.
    Horenblas, S.
    Peters, J.
    Shamash, J.
    Sarwar, N.
    Boletti, K.
    Sadev, A.
    O'Brien, T.
    Berney, D.
    Beltran, L.
    Haanen, J.
    Bex, A.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1041 - 1047
  • [49] Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma
    Elfiky, Aymen A.
    Cho, Daniel C.
    McDermott, David F.
    Rosenberg, Jonathan E.
    Fortner, Barry
    Antras, Lucia
    Chen, Kristina
    Duh, Mei Sheng
    Jayawant, Sujata S.
    Oh, William K.
    Atkins, Michael B.
    Choueiri, Toni K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (06) : 756 - 763
  • [50] Role of Cytoreductive Nephrectomy in Metastatic Clear Cell Renal cell Carcinoma in the Era of immunotherapy: An Analysis of the National Cancer Database
    Zerdan, Maroun Bou
    Niforatos, Stephanie
    Arunachalam, Swathi
    Jamaspishvili, Tamara
    Wong, Roger
    Bratslavsky, Gennady
    Jacob, Joseph
    Ross, Jeffrey
    Shapiro, Oleg
    Goldberg, Hanan
    Basnet, Alina
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)